As of 2025-06-21, the EV/EBITDA ratio of Marinus Pharmaceuticals Inc (MRNS) is -0.36. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRNS's latest enterprise value is 43.38 mil USD. MRNS's TTM EBITDA according to its financial statements is -121.83 mil USD. Dividing these 2 quantities gives us the above MRNS EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.1x - 8.5x | 7.8x |
| Forward P/E multiples | 6.2x - 9.5x | 7.6x |
| Fair Price | (15.81) - (18.94) | (17.33) |
| Upside | -2974.8% - -3544.4% | -3251.6% |
| Date | EV/EBITDA |